Global Retinoblastoma Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Retina is the third-inner layer of the eye, responsible for light and color detection. Retinoblastoma is a rare type of cancer which develops in the retina, particularly in children.
Scope of the Report:
In terms of drugs, the retinoblastoma treatment market can be segmented into single drugs and combinatory drugs. By types, the retinoblastoma treatment market can be categorized into unilateral retinoblastoma, bilateral retinoblastoma, and neuro-ectodermal tumors retinoblastoma. Based on delivery of drugs, the retinoblastoma treatment market can be classified into intravitreal, intra-arterial, peiocular, and others. In terms of end-user, the retinoblastoma treatment market can be divided into hospitals, independent eye clinics, and others.
The global Retinoblastoma Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Retinoblastoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Retinoblastoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Retinoblastoma Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Scope of the Report:
In terms of drugs, the retinoblastoma treatment market can be segmented into single drugs and combinatory drugs. By types, the retinoblastoma treatment market can be categorized into unilateral retinoblastoma, bilateral retinoblastoma, and neuro-ectodermal tumors retinoblastoma. Based on delivery of drugs, the retinoblastoma treatment market can be classified into intravitreal, intra-arterial, peiocular, and others. In terms of end-user, the retinoblastoma treatment market can be divided into hospitals, independent eye clinics, and others.
The global Retinoblastoma Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Retinoblastoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Retinoblastoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Retinoblastoma Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Baxter International
- GlaxoSmithKline
- Pfizer
- Bristol-Myers Squibb
- Merck & Co.
- Johnson & Johnson
- Novartis
- Cadila Pharmaceuticals
- Teva Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Surgery
- Radiation therapy
- Laser Therapy (Photocoagulation)
- Cryotherapy
- Thermotherapy
- Chemotherapy
- Congenital (Hereditary) Retinoblastoma
- Sporadic (Non-Hereditary) Retinoblastoma
1 RETINOBLASTOMA TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Retinoblastoma Treatment
1.2 Classification of Retinoblastoma Treatment by Types
1.2.1 Global Retinoblastoma Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Retinoblastoma Treatment Revenue Market Share by Types in 2017
1.2.3 Surgery
1.2.4 Radiation therapy
1.2.5 Laser Therapy (Photocoagulation)
1.2.6 Cryotherapy
1.2.7 Thermotherapy
1.2.8 Chemotherapy
1.3 Global Retinoblastoma Treatment Market by Application
1.3.1 Global Retinoblastoma Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Congenital (Hereditary) Retinoblastoma
1.3.3 Sporadic (Non-Hereditary) Retinoblastoma
1.4 Global Retinoblastoma Treatment Market by Regions
1.4.1 Global Retinoblastoma Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Retinoblastoma Treatment (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Baxter International
2.1.1 Business Overview
2.1.2 Retinoblastoma Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter International Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Retinoblastoma Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Retinoblastoma Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Retinoblastoma Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck & Co.
2.5.1 Business Overview
2.5.2 Retinoblastoma Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck & Co. Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Retinoblastoma Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Retinoblastoma Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cadila Pharmaceuticals
2.8.1 Business Overview
2.8.2 Retinoblastoma Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cadila Pharmaceuticals Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical
2.9.1 Business Overview
2.9.2 Retinoblastoma Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL RETINOBLASTOMA TREATMENT MARKET COMPETITION, BY PLAYERS
3.1 Global Retinoblastoma Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Retinoblastoma Treatment Players Market Share
3.2.2 Top 10 Retinoblastoma Treatment Players Market Share
3.3 Market Competition Trend
4 GLOBAL RETINOBLASTOMA TREATMENT MARKET SIZE BY REGIONS
4.1 Global Retinoblastoma Treatment Revenue and Market Share by Regions
4.2 North America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
5.1 North America Retinoblastoma Treatment Revenue by Countries (2013-2018)
5.2 USA Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6 EUROPE RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
6.1 Europe Retinoblastoma Treatment Revenue by Countries (2013-2018)
6.2 Germany Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.4 France Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
7.1 Asia-Pacific Retinoblastoma Treatment Revenue by Countries (2013-2018)
7.2 China Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.5 India Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
8.1 South America Retinoblastoma Treatment Revenue by Countries (2013-2018)
8.2 Brazil Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE RETINOBLASTOMA TREATMENT BY COUNTRIES
9.1 Middle East and Africa Retinoblastoma Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
10 GLOBAL RETINOBLASTOMA TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Retinoblastoma Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Retinoblastoma Treatment Market Forecast by Type (2018-2023)
10.3 Surgery Revenue Growth Rate (2013-2023)
10.4 Radiation therapy Revenue Growth Rate (2013-2023)
10.5 Laser Therapy (Photocoagulation) Revenue Growth Rate (2013-2023)
10.6 Cryotherapy Revenue Growth Rate (2013-2023)
10.7 Thermotherapy Revenue Growth Rate (2013-2023)
10.8 Chemotherapy Revenue Growth Rate (2013-2023)
11 GLOBAL RETINOBLASTOMA TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Retinoblastoma Treatment Revenue Market Share by Application (2013-2018)
11.2 Retinoblastoma Treatment Market Forecast by Application (2018-2023)
11.3 Congenital (Hereditary) Retinoblastoma Revenue Growth (2013-2018)
11.4 Sporadic (Non-Hereditary) Retinoblastoma Revenue Growth (2013-2018)
12 GLOBAL RETINOBLASTOMA TREATMENT MARKET SIZE FORECAST (2018-2023)
12.1 Global Retinoblastoma Treatment Market Size Forecast (2018-2023)
12.2 Global Retinoblastoma Treatment Market Forecast by Regions (2018-2023)
12.3 North America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.6 South America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Retinoblastoma Treatment
1.2 Classification of Retinoblastoma Treatment by Types
1.2.1 Global Retinoblastoma Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Retinoblastoma Treatment Revenue Market Share by Types in 2017
1.2.3 Surgery
1.2.4 Radiation therapy
1.2.5 Laser Therapy (Photocoagulation)
1.2.6 Cryotherapy
1.2.7 Thermotherapy
1.2.8 Chemotherapy
1.3 Global Retinoblastoma Treatment Market by Application
1.3.1 Global Retinoblastoma Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Congenital (Hereditary) Retinoblastoma
1.3.3 Sporadic (Non-Hereditary) Retinoblastoma
1.4 Global Retinoblastoma Treatment Market by Regions
1.4.1 Global Retinoblastoma Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retinoblastoma Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Retinoblastoma Treatment (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Baxter International
2.1.1 Business Overview
2.1.2 Retinoblastoma Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Baxter International Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Retinoblastoma Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Retinoblastoma Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Retinoblastoma Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck & Co.
2.5.1 Business Overview
2.5.2 Retinoblastoma Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck & Co. Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Retinoblastoma Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Retinoblastoma Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cadila Pharmaceuticals
2.8.1 Business Overview
2.8.2 Retinoblastoma Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cadila Pharmaceuticals Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Teva Pharmaceutical
2.9.1 Business Overview
2.9.2 Retinoblastoma Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teva Pharmaceutical Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL RETINOBLASTOMA TREATMENT MARKET COMPETITION, BY PLAYERS
3.1 Global Retinoblastoma Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Retinoblastoma Treatment Players Market Share
3.2.2 Top 10 Retinoblastoma Treatment Players Market Share
3.3 Market Competition Trend
4 GLOBAL RETINOBLASTOMA TREATMENT MARKET SIZE BY REGIONS
4.1 Global Retinoblastoma Treatment Revenue and Market Share by Regions
4.2 North America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
5.1 North America Retinoblastoma Treatment Revenue by Countries (2013-2018)
5.2 USA Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6 EUROPE RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
6.1 Europe Retinoblastoma Treatment Revenue by Countries (2013-2018)
6.2 Germany Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.4 France Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
7.1 Asia-Pacific Retinoblastoma Treatment Revenue by Countries (2013-2018)
7.2 China Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.5 India Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA RETINOBLASTOMA TREATMENT REVENUE BY COUNTRIES
8.1 South America Retinoblastoma Treatment Revenue by Countries (2013-2018)
8.2 Brazil Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE RETINOBLASTOMA TREATMENT BY COUNTRIES
9.1 Middle East and Africa Retinoblastoma Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
10 GLOBAL RETINOBLASTOMA TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Retinoblastoma Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Retinoblastoma Treatment Market Forecast by Type (2018-2023)
10.3 Surgery Revenue Growth Rate (2013-2023)
10.4 Radiation therapy Revenue Growth Rate (2013-2023)
10.5 Laser Therapy (Photocoagulation) Revenue Growth Rate (2013-2023)
10.6 Cryotherapy Revenue Growth Rate (2013-2023)
10.7 Thermotherapy Revenue Growth Rate (2013-2023)
10.8 Chemotherapy Revenue Growth Rate (2013-2023)
11 GLOBAL RETINOBLASTOMA TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Retinoblastoma Treatment Revenue Market Share by Application (2013-2018)
11.2 Retinoblastoma Treatment Market Forecast by Application (2018-2023)
11.3 Congenital (Hereditary) Retinoblastoma Revenue Growth (2013-2018)
11.4 Sporadic (Non-Hereditary) Retinoblastoma Revenue Growth (2013-2018)
12 GLOBAL RETINOBLASTOMA TREATMENT MARKET SIZE FORECAST (2018-2023)
12.1 Global Retinoblastoma Treatment Market Size Forecast (2018-2023)
12.2 Global Retinoblastoma Treatment Market Forecast by Regions (2018-2023)
12.3 North America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.6 South America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Retinoblastoma Treatment Picture
Table Product Specifications of Retinoblastoma Treatment
Table Global Retinoblastoma Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Retinoblastoma Treatment Revenue Market Share by Types in 2017
Figure Surgery Picture
Figure Radiation therapy Picture
Figure Laser Therapy (Photocoagulation) Picture
Figure Cryotherapy Picture
Figure Thermotherapy Picture
Figure Chemotherapy Picture
Table Global Retinoblastoma Treatment Revenue (Million USD) by Application (2013-2023)
Figure Retinoblastoma Treatment Revenue Market Share by Applications in 2017
Figure Congenital (Hereditary) Retinoblastoma Picture
Figure Sporadic (Non-Hereditary) Retinoblastoma Picture
Table Global Market Retinoblastoma Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Baxter International Basic Information, Manufacturing Base and Competitors
Table Baxter International Retinoblastoma Treatment Type and Applications
Table Baxter International Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Retinoblastoma Treatment Type and Applications
Table GlaxoSmithKline Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Retinoblastoma Treatment Type and Applications
Table Pfizer Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Retinoblastoma Treatment Type and Applications
Table Bristol-Myers Squibb Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Retinoblastoma Treatment Type and Applications
Table Merck & Co. Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Retinoblastoma Treatment Type and Applications
Table Johnson & Johnson Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Retinoblastoma Treatment Type and Applications
Table Novartis Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharmaceuticals Retinoblastoma Treatment Type and Applications
Table Cadila Pharmaceuticals Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Retinoblastoma Treatment Type and Applications
Table Teva Pharmaceutical Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Retinoblastoma Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Retinoblastoma Treatment Revenue Share by Players (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Players in 2016
Figure Global Retinoblastoma Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Retinoblastoma Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Retinoblastoma Treatment Revenue Market Share in 2017
Figure Global Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Retinoblastoma Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Retinoblastoma Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Market Share by Regions in 2017
Figure North America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure South America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table North America Retinoblastoma Treatment Revenue by Countries (2013-2018)
Table North America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure USA Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Europe Retinoblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure Germany Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure UK Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure France Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Retinoblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure China Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure India Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table South America Retinoblastoma Treatment Revenue by Countries (2013-2018)
Table South America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure Brazil Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Retinoblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Global Retinoblastoma Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Retinoblastoma Treatment Revenue Share by Type (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Type (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Type in 2017
Table Global Retinoblastoma Treatment Revenue Forecast by Type (2018-2023)
Figure Global Retinoblastoma Treatment Market Share Forecast by Type (2018-2023)
Figure Global Surgery Revenue Growth Rate (2013-2018)
Figure Global Radiation therapy Revenue Growth Rate (2013-2018)
Figure Global Laser Therapy (Photocoagulation) Revenue Growth Rate (2013-2018)
Figure Global Cryotherapy Revenue Growth Rate (2013-2018)
Figure Global Thermotherapy Revenue Growth Rate (2013-2018)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Table Global Retinoblastoma Treatment Revenue by Application (2013-2018)
Table Global Retinoblastoma Treatment Revenue Share by Application (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Application (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Application in 2017
Table Global Retinoblastoma Treatment Revenue Forecast by Application (2018-2023)
Figure Global Retinoblastoma Treatment Market Share Forecast by Application (2018-2023)
Figure Global Congenital (Hereditary) Retinoblastoma Revenue Growth Rate (2013-2018)
Figure Global Sporadic (Non-Hereditary) Retinoblastoma Revenue Growth Rate (2013-2018)
Figure Global Retinoblastoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Retinoblastoma Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Retinoblastoma Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Europe Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure South America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Retinoblastoma Treatment Picture
Table Product Specifications of Retinoblastoma Treatment
Table Global Retinoblastoma Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Retinoblastoma Treatment Revenue Market Share by Types in 2017
Figure Surgery Picture
Figure Radiation therapy Picture
Figure Laser Therapy (Photocoagulation) Picture
Figure Cryotherapy Picture
Figure Thermotherapy Picture
Figure Chemotherapy Picture
Table Global Retinoblastoma Treatment Revenue (Million USD) by Application (2013-2023)
Figure Retinoblastoma Treatment Revenue Market Share by Applications in 2017
Figure Congenital (Hereditary) Retinoblastoma Picture
Figure Sporadic (Non-Hereditary) Retinoblastoma Picture
Table Global Market Retinoblastoma Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Baxter International Basic Information, Manufacturing Base and Competitors
Table Baxter International Retinoblastoma Treatment Type and Applications
Table Baxter International Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Retinoblastoma Treatment Type and Applications
Table GlaxoSmithKline Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Retinoblastoma Treatment Type and Applications
Table Pfizer Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Retinoblastoma Treatment Type and Applications
Table Bristol-Myers Squibb Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Retinoblastoma Treatment Type and Applications
Table Merck & Co. Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Retinoblastoma Treatment Type and Applications
Table Johnson & Johnson Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Retinoblastoma Treatment Type and Applications
Table Novartis Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharmaceuticals Retinoblastoma Treatment Type and Applications
Table Cadila Pharmaceuticals Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Retinoblastoma Treatment Type and Applications
Table Teva Pharmaceutical Retinoblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Retinoblastoma Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Retinoblastoma Treatment Revenue Share by Players (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Players in 2016
Figure Global Retinoblastoma Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Retinoblastoma Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Retinoblastoma Treatment Revenue Market Share in 2017
Figure Global Retinoblastoma Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Retinoblastoma Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Retinoblastoma Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Market Share by Regions in 2017
Figure North America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure South America Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table North America Retinoblastoma Treatment Revenue by Countries (2013-2018)
Table North America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure USA Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Europe Retinoblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure Germany Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure UK Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure France Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Retinoblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure China Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure India Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table South America Retinoblastoma Treatment Revenue by Countries (2013-2018)
Table South America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure Brazil Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Retinoblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Retinoblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Retinoblastoma Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Retinoblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Global Retinoblastoma Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Retinoblastoma Treatment Revenue Share by Type (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Type (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Type in 2017
Table Global Retinoblastoma Treatment Revenue Forecast by Type (2018-2023)
Figure Global Retinoblastoma Treatment Market Share Forecast by Type (2018-2023)
Figure Global Surgery Revenue Growth Rate (2013-2018)
Figure Global Radiation therapy Revenue Growth Rate (2013-2018)
Figure Global Laser Therapy (Photocoagulation) Revenue Growth Rate (2013-2018)
Figure Global Cryotherapy Revenue Growth Rate (2013-2018)
Figure Global Thermotherapy Revenue Growth Rate (2013-2018)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Table Global Retinoblastoma Treatment Revenue by Application (2013-2018)
Table Global Retinoblastoma Treatment Revenue Share by Application (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Application (2013-2018)
Figure Global Retinoblastoma Treatment Revenue Share by Application in 2017
Table Global Retinoblastoma Treatment Revenue Forecast by Application (2018-2023)
Figure Global Retinoblastoma Treatment Market Share Forecast by Application (2018-2023)
Figure Global Congenital (Hereditary) Retinoblastoma Revenue Growth Rate (2013-2018)
Figure Global Sporadic (Non-Hereditary) Retinoblastoma Revenue Growth Rate (2013-2018)
Figure Global Retinoblastoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Retinoblastoma Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Retinoblastoma Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Europe Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure South America Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Retinoblastoma Treatment Revenue Market Forecast (2018-2023)
